Neonatal Seizures: A Review of Outcomes and Outcome Predictors

Francesco Pisani1, Carlotta Spagnoli1

  • 1Child Neuropsychiatry Unit, Neuroscience Department, University of Parma, Parma, Italy.

Neuropediatrics
|November 21, 2015
PubMed

Insights

Neonatal seizures, often acute and symptomatic, increase mortality and morbidity risks. Integrating clinical and EEG findings improves early prediction of outcomes like epilepsy and cerebral palsy.

Area of Science:

  • Neonatology
  • Neurology
  • Pediatric Neurology

Background:

  • Neonatal seizures are frequently acute and symptomatic, linked to increased mortality and morbidity.
  • While etiology is a key prognostic factor, other elements like gestational age and brain injury severity also influence outcomes.
  • Accurate early prognostication requires integrating diverse clinical and instrumental data.

Purpose of the Study:

  • To review the outcomes of neonatal seizures, including mortality, epilepsy, cerebral palsy, and intellectual disability.
  • To identify risk factors for adverse outcomes, considering clinical, EEG, and neuroimaging findings.
  • To examine existing scoring systems for predicting neurological outcomes in neonates with seizures.

Main Methods:

  • Systematic literature review of studies on neonatal seizures and their outcomes.
  • Analysis of clinical, electroencephalography (EEG), amplitude-integrated EEG (aEEG), and neuroimaging data.
  • Evaluation of prognostic scoring systems for neonatal seizures.

Main Results:

  • Neonatal seizures are associated with significant risks of mortality, epilepsy, cerebral palsy, and intellectual disability.
  • Clinical factors, gestational age, brain damage severity, and EEG characteristics are crucial predictors of outcome.
  • Certain EEG and neuroimaging findings correlate with adverse outcomes and treatment resistance.

Conclusions:

  • Early and accurate prognostication in neonatal seizures is achievable by combining various clinical and instrumental data.
  • Understanding risk factors is essential for guiding management and improving neurodevelopmental outcomes.
  • Further research into refining prognostic tools is warranted to optimize care for affected newborns.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K